4164
SA:NAHDI
Nahdi Medical Company
- Stock
Last Close
119.20
25/11 09:25
Market Cap
17.26B
Beta: -
Volume Today
106.63K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 1.21B - | 1.15B - | ||||
average payables | 480.61M - | 560.58M - | ||||
average receivables | 170.52M - | 135.24M - | ||||
book value per share | 13.73 - | 15.99 16.50% | 12.34 22.86% | 17.26 39.90% | ||
capex per share | -1.80 - | -2.46 36.42% | -2.36 4.17% | -2.12 10.19% | ||
capex to depreciation | -0.47 - | -0.62 30.42% | -0.54 13.12% | -0.46 13.98% | ||
capex to operating cash flow | -0.17 - | -0.20 15.97% | -0.23 13.93% | -0.17 28.17% | ||
capex to revenue | -0.03 - | -0.04 23.52% | -0.04 2.67% | -0.03 15.92% | ||
cash per share | 4.42 - | 7.76 75.34% | 3.08 60.23% | 8.28 168.38% | ||
days of inventory on hand | 74.99 - | 77.30 3.08% | 85.58 10.72% | 84.73 1.00% | ||
days payables outstanding | 32.47 - | 27.89 14.11% | 37.10 33.04% | 45.64 23.02% | ||
days sales outstanding | 8.77 - | 6.46 26.38% | 6.35 1.72% | 5.52 13.11% | ||
debt to assets | 0.06 - | 0.09 56.24% | 0.32 264.23% | 0.24 25.49% | ||
debt to equity | 0.13 - | 0.20 49.47% | 0.85 333.80% | 0.52 38.56% | ||
dividend yield | 0.02 - | 0.02 7.00% | 0.06 135.51% | 0.01 76.64% | ||
earnings yield | 0.03 - | 0.04 22.70% | 0.04 4.31% | 0.04 7.10% | ||
enterprise value | 22.71B - | 22.09B 2.72% | 22.82B 3.31% | 22.40B 1.86% | ||
enterprise value over ebitda | 17.36 - | 14.95 13.87% | 15.65 4.64% | 14.01 10.48% | ||
ev to operating cash flow | 16.85 - | 13.93 17.31% | 17.11 22.82% | 13.43 21.51% | ||
ev to sales | 2.90 - | 2.56 11.93% | 2.83 10.69% | 2.60 8.12% | ||
free cash flow per share | 8.57 - | 9.74 13.68% | 7.90 18.84% | 10.71 35.54% | ||
free cash flow yield | 0.05 - | 0.06 13.68% | 0.05 18.84% | 0.06 32.85% | ||
graham net net | -8.34 - | -6.57 21.26% | -12.45 89.61% | -7.20 42.17% | ||
graham number | 40.55 - | 48.48 19.56% | 41.65 14.08% | 51.49 23.64% | ||
income quality | 1.95 - | 1.87 4.13% | 1.56 16.68% | 1.78 14.28% | ||
intangibles to total assets | 0 - | 0 | 0.01 Infinity% | 0.01 7.71% | 0 100% | |
interest coverage | 14.68 - | 16.68 13.62% | 11.66 30.12% | 12.63 8.35% | ||
interest debt per share | 2.22 - | 3.57 60.66% | 11.06 210.15% | 9.60 13.25% | ||
inventory turnover | 4.87 - | 4.72 2.99% | 4.26 9.68% | 4.31 1.01% | ||
invested capital | 0.13 - | 0.20 49.47% | 0.85 333.80% | 0.52 38.56% | ||
market cap | 21.87B - | 21.87B 0% | 21.87B 0% | 22.31B 2.02% | ||
net current asset value | -402.49M - | -160.40M 60.15% | -883.95M 451.10% | -137.88M 84.40% | ||
net debt to ebitda | 0.65 - | 0.15 76.27% | 0.66 328.31% | 0.06 91.26% | ||
net income per share | 5.32 - | 6.53 22.70% | 6.25 4.31% | 6.83 9.27% | ||
operating cash flow per share | 10.37 - | 12.20 17.64% | 10.26 15.88% | 12.83 25.03% | ||
payables turnover | 11.24 - | 13.09 16.43% | 9.84 24.84% | 8.00 18.71% | ||
receivables turnover | 41.60 - | 56.51 35.84% | 57.50 1.75% | 66.18 15.09% | ||
research and ddevelopement to revenue | ||||||
return on tangible assets | 0.17 - | 0.18 10.09% | 0.19 5.24% | 0.18 5.35% | ||
revenue per share | 60.19 - | 66.48 10.45% | 62.05 6.66% | 66.28 6.82% | ||
roe | 0.39 - | 0.41 5.33% | 0.51 24.05% | 0.40 21.90% | ||
roic | 0.24 - | 0.27 12.73% | 0.20 26.61% | 0.21 2.75% | ||
sales general and administrative to revenue | 0.01 - | 0.01 23.35% | ||||
shareholders equity per share | 13.73 - | 15.99 16.50% | 12.34 22.86% | 17.26 39.90% | ||
stock based compensation to revenue | ||||||
tangible asset value | 1.78B - | 2.08B 16.50% | 1.56B 24.99% | 2.20B 40.85% | ||
tangible book value per share | 13.73 - | 15.99 16.50% | 12.00 24.99% | 16.89 40.85% | ||
working capital | 750.75M - | 1.01B 34.85% | 513.51M 49.28% | 1.06B 105.50% |
All numbers in SAR (except ratios and percentages)